Clinical Trial Update: Efficacy of Cholesterol-lowering L. Plantarum on Cardiometabolic Health Biomarkers in Coeliac Disease Patients [NA]

View source ↗

Summary

The University of Roehampton is investigating whether the cholesterol-lowering probiotic Lactobacillus plantarum improves cardiometabolic biomarkers in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Lactobacillus plantarum (Lactobacillus plantarum)

Snippet

Sponsor: University of Roehampton | Conditions: Celiac Disease | NA | Status: ACTIVE_NOT_RECRUITING